학술논문
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial
Document Type
Article
Author
Sundén-Cullberg, J.; Asgeirsson, H.; Blennow, O.; Parke, Å.; Svensson, A.-K.; Sönnerborg, A.; Vesterbacka, J.; Nowak, P.; Chen, P.; Muvva, J.R.; Ljunggren, H.-G.; Häbel, H.; Skorup, P.; Janols, H.; Rasmuson, J.; Niward, K.; Balkhed, Å.Ö.; Chatzidionysiou, K.; Lampa, J.; Horne, A.-C.; Ådén, U.; Henter, J.-I.
Source
In: PLoS ONE . (PLoS ONE, December 2023, 18 12 December)
Subject
Language
English
ISSN
19326203